Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Equity Ratio (2016 - 2025)

Ocular Therapeutix (OCUL) has 13 years of Equity Ratio data on record, last reported at 0.81 in Q4 2025.

  • For Q4 2025, Equity Ratio rose 17.59% year-over-year to 0.81; the TTM value through Dec 2025 reached 0.81, up 17.59%, while the annual FY2025 figure was 0.81, 17.59% up from the prior year.
  • Equity Ratio reached 0.81 in Q4 2025 per OCUL's latest filing, up from 0.63 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.81 in Q4 2025 and bottomed at 0.03 in Q2 2023.
  • Average Equity Ratio over 5 years is 0.45, with a median of 0.41 recorded in 2021.
  • Peak YoY movement for Equity Ratio: crashed 93.38% in 2023, then skyrocketed 2799.88% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.43 in 2021, then plummeted by 44.82% to 0.24 in 2022, then skyrocketed by 52.56% to 0.36 in 2023, then surged by 90.47% to 0.69 in 2024, then grew by 17.59% to 0.81 in 2025.
  • Per Business Quant database, its latest 3 readings for Equity Ratio were 0.81 in Q4 2025, 0.63 in Q3 2025, and 0.68 in Q2 2025.